As with all modern trials, ensuring that disparate data can be easily integrated and available on-demand to users for review analysis is key for fast decision making and critical for the clinical programs. Beyond regulatory compliance, the safety of patients is foremost on researchers minds. Sponsors are now trying to do something new but realizing that old tools that are not up to the task keeps data siloed, adding time and risk as clinical teams jump between systems, hunting down needed information or relying on vendors to deliver reports that can lag a month behind the study.
More complexity means intensive data capture and continuous flows are essential so vital strategic decisions can be made using real-time data analysis and intelligence.
In this webinar the panel will discuss:
- The impact of waiting for and aggregating reports
- Time
- Costs
- Risks
- Key barriers to getting needed data
- The importance of a holistic clinical data strategy for small and mid-sized biotech and pharmaceutical sponsors
- Defining organizational and clinical program requirements
- Partner selection: best of breed, platform, hybrid
- New technologies to consider like eSource for DCT/hybrid, data science tools, data repositories
The goal of this webinar is to discuss the approaches to address the pain around remotely collecting and integrating disparate data, selecting the right technologies, and the value of powerful visualizations to give you the insights, down to the source level, to take action and optimize your trials.
Key Learning Objectives
- Understand the impact of reporting delays
- Key barriers to getting needed trial data
- The importance of a holistic clinical data strategy for small and mid-sized biotech and pharmaceutical sponsors
- New data technologies to consider
